Anti-tumor effect of combined treatment with thymosin alpha 1 and interleukin-2 after 5-fluorouracil in liver metastases from colorectal cancer in rats

G. Rasi, G. Silecchia, P. Sinibaldi-Vallebona, E. Spaziani, P. Pierimarchi, M. Sivilia, S. Tremiterra, E. Garaci

Research output: Contribution to journalArticle

Abstract

We studied the effect of combined chemo-immunotherapy, 5-FU followed by thymosin αI (TαI) and interleukin-2 (IL-2) at low doses, on liver metastases from colorectal cancer, induced by splenic injection of DHD/K12 cells (1,2-dimethylhydrazine-induced colon adenocarcinoma) in syngeneic BDIX rats. The presence of liver metastases was checked by laparotomy 14 days after tumor-cell injection. Evaluable rats were assigned randomly to 5 experimental groups designated as control, 5-FU, IL-2, 5-FU/IL-2 and 5- FU/TαI/IL-2. 5-FU was administered i.v. as a continuous infusion for 7 days by an osmotic device implanted surgically. TαI and IL-2 were administered for 4 days and repeated after 11 days. Combined chemo-immunotherapy was shown both to significantly reduce the growth of liver metastases and to prevent extra-hepatic spread. 5-FU/TαI/IL-2 also improved survival rate. Combined immunotherapy after 5-FU restored NK activity of the peripheral-blood- mononuclear-cell (PBMC) in tumor and/or 5-FU immunodepressed rats and enhanced PBMC cytotoxic activity against the DHD/K12 autologous cell line. This model was devised to mimic the clinical situation of unresectable liver metastases.

Original languageEnglish
Pages (from-to)701-705
Number of pages5
JournalInternational Journal of Cancer
Volume57
Issue number5
DOIs
Publication statusPublished - 1994

Fingerprint

Fluorouracil
Interleukin-2
Colorectal Neoplasms
Neoplasm Metastasis
Thymosin
Liver
Neoplasms
Immunotherapy
Interleukin-5
Therapeutics
Blood Cells
1,2-Dimethylhydrazine
Injections
thymalfasin
Laparotomy
Colon
Adenocarcinoma
Cell Line
Equipment and Supplies
Growth

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Anti-tumor effect of combined treatment with thymosin alpha 1 and interleukin-2 after 5-fluorouracil in liver metastases from colorectal cancer in rats. / Rasi, G.; Silecchia, G.; Sinibaldi-Vallebona, P.; Spaziani, E.; Pierimarchi, P.; Sivilia, M.; Tremiterra, S.; Garaci, E.

In: International Journal of Cancer, Vol. 57, No. 5, 1994, p. 701-705.

Research output: Contribution to journalArticle

Rasi, G. ; Silecchia, G. ; Sinibaldi-Vallebona, P. ; Spaziani, E. ; Pierimarchi, P. ; Sivilia, M. ; Tremiterra, S. ; Garaci, E. / Anti-tumor effect of combined treatment with thymosin alpha 1 and interleukin-2 after 5-fluorouracil in liver metastases from colorectal cancer in rats. In: International Journal of Cancer. 1994 ; Vol. 57, No. 5. pp. 701-705.
@article{367d96c6e2dd4c66a503edbe980f2e84,
title = "Anti-tumor effect of combined treatment with thymosin alpha 1 and interleukin-2 after 5-fluorouracil in liver metastases from colorectal cancer in rats",
abstract = "We studied the effect of combined chemo-immunotherapy, 5-FU followed by thymosin αI (TαI) and interleukin-2 (IL-2) at low doses, on liver metastases from colorectal cancer, induced by splenic injection of DHD/K12 cells (1,2-dimethylhydrazine-induced colon adenocarcinoma) in syngeneic BDIX rats. The presence of liver metastases was checked by laparotomy 14 days after tumor-cell injection. Evaluable rats were assigned randomly to 5 experimental groups designated as control, 5-FU, IL-2, 5-FU/IL-2 and 5- FU/TαI/IL-2. 5-FU was administered i.v. as a continuous infusion for 7 days by an osmotic device implanted surgically. TαI and IL-2 were administered for 4 days and repeated after 11 days. Combined chemo-immunotherapy was shown both to significantly reduce the growth of liver metastases and to prevent extra-hepatic spread. 5-FU/TαI/IL-2 also improved survival rate. Combined immunotherapy after 5-FU restored NK activity of the peripheral-blood- mononuclear-cell (PBMC) in tumor and/or 5-FU immunodepressed rats and enhanced PBMC cytotoxic activity against the DHD/K12 autologous cell line. This model was devised to mimic the clinical situation of unresectable liver metastases.",
author = "G. Rasi and G. Silecchia and P. Sinibaldi-Vallebona and E. Spaziani and P. Pierimarchi and M. Sivilia and S. Tremiterra and E. Garaci",
year = "1994",
doi = "10.1002/ijc.2910570516",
language = "English",
volume = "57",
pages = "701--705",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "5",

}

TY - JOUR

T1 - Anti-tumor effect of combined treatment with thymosin alpha 1 and interleukin-2 after 5-fluorouracil in liver metastases from colorectal cancer in rats

AU - Rasi, G.

AU - Silecchia, G.

AU - Sinibaldi-Vallebona, P.

AU - Spaziani, E.

AU - Pierimarchi, P.

AU - Sivilia, M.

AU - Tremiterra, S.

AU - Garaci, E.

PY - 1994

Y1 - 1994

N2 - We studied the effect of combined chemo-immunotherapy, 5-FU followed by thymosin αI (TαI) and interleukin-2 (IL-2) at low doses, on liver metastases from colorectal cancer, induced by splenic injection of DHD/K12 cells (1,2-dimethylhydrazine-induced colon adenocarcinoma) in syngeneic BDIX rats. The presence of liver metastases was checked by laparotomy 14 days after tumor-cell injection. Evaluable rats were assigned randomly to 5 experimental groups designated as control, 5-FU, IL-2, 5-FU/IL-2 and 5- FU/TαI/IL-2. 5-FU was administered i.v. as a continuous infusion for 7 days by an osmotic device implanted surgically. TαI and IL-2 were administered for 4 days and repeated after 11 days. Combined chemo-immunotherapy was shown both to significantly reduce the growth of liver metastases and to prevent extra-hepatic spread. 5-FU/TαI/IL-2 also improved survival rate. Combined immunotherapy after 5-FU restored NK activity of the peripheral-blood- mononuclear-cell (PBMC) in tumor and/or 5-FU immunodepressed rats and enhanced PBMC cytotoxic activity against the DHD/K12 autologous cell line. This model was devised to mimic the clinical situation of unresectable liver metastases.

AB - We studied the effect of combined chemo-immunotherapy, 5-FU followed by thymosin αI (TαI) and interleukin-2 (IL-2) at low doses, on liver metastases from colorectal cancer, induced by splenic injection of DHD/K12 cells (1,2-dimethylhydrazine-induced colon adenocarcinoma) in syngeneic BDIX rats. The presence of liver metastases was checked by laparotomy 14 days after tumor-cell injection. Evaluable rats were assigned randomly to 5 experimental groups designated as control, 5-FU, IL-2, 5-FU/IL-2 and 5- FU/TαI/IL-2. 5-FU was administered i.v. as a continuous infusion for 7 days by an osmotic device implanted surgically. TαI and IL-2 were administered for 4 days and repeated after 11 days. Combined chemo-immunotherapy was shown both to significantly reduce the growth of liver metastases and to prevent extra-hepatic spread. 5-FU/TαI/IL-2 also improved survival rate. Combined immunotherapy after 5-FU restored NK activity of the peripheral-blood- mononuclear-cell (PBMC) in tumor and/or 5-FU immunodepressed rats and enhanced PBMC cytotoxic activity against the DHD/K12 autologous cell line. This model was devised to mimic the clinical situation of unresectable liver metastases.

UR - http://www.scopus.com/inward/record.url?scp=0028287389&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028287389&partnerID=8YFLogxK

U2 - 10.1002/ijc.2910570516

DO - 10.1002/ijc.2910570516

M3 - Article

C2 - 8194879

AN - SCOPUS:0028287389

VL - 57

SP - 701

EP - 705

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 5

ER -